We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
A picture of Xiaobo Wang

Xiaobo Wang profile page

Vice President and General Manager, Cell Function and Phenotyping

 at Agilent Technologies


Dr. Xiaobo Wang is vice president and general manager of Agilent’s Cell Function and Phenotyping Business. Since joining Agilent in 2018 through the acquisition of ACEA Biosciences, Dr. Wang has led the development and commercialization of real-time cell analysis platforms and next-generation flow cytometry systems. His focus on meeting customer needs in cell gene therapy and immune-oncology markets has driven the adoption of cell analysis technologies. Before Agilent, Wang co-founded ACEA Biosciences, where he pioneered electronic sensor platforms for label-free, real-time cell-based assays and NovoCyte flow cytometry technologies. With over 60 scientific publications and 50 US patents, Xiaobo Wang continues to shape cell analysis and biosensor advancements.


Got a Question for Xiaobo Wang?


Get in touch using the contact form linked here and we’ll get back to you shortly.



Advertisement